Abraham Ceesay Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity
Abraham Ceesay is President of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Sep 08, 2022, when has been sold 19,210 shares (Common Stock) at a price of $32.5 per share, resulting in proceeds of $624,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Abraham Ceesay Transaction History
Also insider at
AC
Abraham Ceesay
President
Cambridge, MA